Isabel Barragán (Isabel Barragan, I Barragán)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Venues

International journal of molecular sciences

British journal of cancer

Biomedicines

Cancers

Instituto de Investigación Biomédica de Málaga

Universidad de Sevilla (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Instituto de Investigación Biomédica de Málaga Mar 01 2020

Spain

Pharmacologist and Geneticist. Nicolas Monardes Programme Senior Researcher, Group Leader. :: Medical Oncology Unit Intercentros

Karolinska Institutet Mar 01 2018

Sweden

Group Leader and Teacher :: Physiology and Pharmacology

Instituto de Investigación Biomédica de Málaga Jan 03 2018 - Feb 28 2020

Spain

Pharmacologist and Geneticist. Senior Researcher Marie Curie. Group Leader. :: Medical Oncology Unit Intercentros

Karolinska Institutet Jun 01 2013 - Feb 28 2018

Sweden

Assistant Professor, Group Leader, Teacher :: Physiology and Pharmacology

Karolinska Institutet Nov 01 2012 - May 31 2013

Sweden

Marie Curie Career Integration Grant fellow :: Physiology and Pharmacology

Karolinska Institutet Oct 01 2011 - Oct 31 2012

Sweden

Postdoctoral researcher :: Physiology and Pharmacology

Spanish Ministry of Research and New Technologies. Center of Biomedical Research on Rare Diseases (CIBERER) National Biomedical Research Foundation Institute of Health Carlos III. Sep 01 2007 - Mar 15 2011

Spain

Postdoctoral researcher :: Clinical Genetics, Fertility and Feta Medicine Service |University Hospital Virgen del Rocío

Regional Ministry of Innovation, Science and Enterprise/ Reina Mercedes Foundation Grant for Biomedical Research Oct 01 2002 - Aug 01 2007

Spain

Predoctoral researcher :: Clinical Genetics, Fertility and Fetal Medicine Service

Regional Ministry of Science Jan 01 2002 - Sep 01 2002

Spain

Assistant Researcher :: Pharmacy and Pharmacy Technology Department

Socrates-Erasmus program Oct 01 2001 - Dec 20 2001

Finland

Predoctoral researcher :: Pharmacy Technology Department

Education History

Universidad de Sevilla Oct 01 2001 - Jun 27 2007

Spain

PHD

Universidad de Sevilla Facultad de Farmacia Oct 01 1996 - Aug 01 2001

Spain

MSC :: Microbiology and Parasitology; Pharmacy and Pharmacy Technology

Publications

Juan Zafra Martín, Juan-Luis Onieva-Zafra, Javier Oliver, María Garrido-Barros, Andrea González-Hernández, Beatriz Martínez-Gálvez, Alicia Román, Rafael Ordóñez-Marmolejo, Elisabeth Perez-Ruiz, Jose Carlos Benitez, Andrés Mesas, Andrés Vera, Rodolfo Chicas-Sett, Antonio Rueda-Domínguez, Isabel Barragán
Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer. International journal of molecular sciences 25 (8) (2024)
Juan Zafra Martín, Juan-Luis Onieva-Zafra, Javier Oliver, María Garrido-Barros, Andrea González-Hernández, Beatriz Martínez-Gálvez, Alicia Román, Rafael Ordóñez-Marmolejo, Elisabeth Perez-Ruiz, Jose Carlos Benitez, Andrés Mesas, Andrés Vera, Rodolfo Chicas-Sett, Antonio Rueda-Domínguez, Isabel Barragán
Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer. International journal of molecular sciences 25 (8) (2024)
Juan Zafra Martín, Juan-Luis Onieva-Zafra, Javier Oliver, María Garrido-Barros, Andrea González-Hernández, Beatriz Martínez-Gálvez, Alicia Román, Rafael Ordóñez-Marmolejo, Elisabeth Perez-Ruiz, Jose Carlos Benitez, Andrés Mesas, Andrés Vera, Rodolfo Chicas-Sett, Antonio Rueda-Domínguez, Isabel Barragán
Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer. International journal of molecular sciences 25 (8) (2024)
Patricia Chaves, María Garrido, Javier Oliver, Elisabeth Perez-Ruiz, Isabel Barragán, Antonio Rueda-Domínguez
Preclinical models in head and neck squamous cell carcinoma. British journal of cancer (2023)
Patricia Chaves, María Garrido, Javier Oliver, Elisabeth Perez-Ruiz, Isabel Barragán, Antonio Rueda-Domínguez
Preclinical models in head and neck squamous cell carcinoma. British journal of cancer (2023)
Patricia Chaves, María Garrido, Javier Oliver, Elisabeth Perez-Ruiz, Isabel Barragán, Antonio Rueda-Domínguez
Preclinical models in head and neck squamous cell carcinoma. British journal of cancer (2023)
Javier Oliver, Juan-Luis Onieva-Zafra, María Garrido-Barros, Manuel Cobo, Beatriz Martínez-Gálvez, Ana Isabel García-Pelícano, Jaime Dubbelman, Jose Carlos Benitez, Juan Zafra Martín, Alejandra Cantero, Elisabeth Perez-Ruiz, Antonio Rueda Domínguez, Isabel Barragán
Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade. Cancers 15 (13) (2023)
Miguel-Angel Berciano-Guerrero, Mora Guardamagna, Elisabeth Perez-Ruiz, Jose-Miguel Jurado, Isabel Barragán, Antonio Rueda-Dominguez
Treatment of Metastatic Melanoma at First Diagnosis: Review of the Literature. Life (Basel, Switzerland) 12 (9) (2022)
Javier Oliver, Juan-Luis Onieva-Zafra, Maria Garrido-Barros, Miguel-Angel Berciano-Guerrero, Alfonso Sánchez-Muñoz, María José Lozano, Angela Farngren, Martina Alvarez, Beatriz Martínez-Gálvez, Elisabeth Perez-Ruiz, Emilio Alba, Manuel Cobo, Antonio Rueda-Domínguez, Isabel Barragán
Association of Circular RNA and Long Non-Coding RNA Dysregulation with the Clinical Response to Immune Checkpoint Blockade in Cutaneous Metastatic Melanoma. Biomedicines 10 (10) (2022)
Jonas Nørskov Søndergaard, Christian Sommerauer, Ionut Atanasoai, Laura C Hinte, Keyi Geng, Giulia Guiducci, Lars Bräutigam, Myriam Aouadi, Lovorka Stojic, Isabel Barragán, Claudia Kutter
CCT3- LINC00326 axis regulates hepatocarcinogenic lipid metabolism. Gut (2022)
Mora Guardamagna, Miguel-Angel Berciano-Guerrero, Beatriz Villaescusa-González, Elisabeth Perez-Ruiz, Javier Oliver, Rocío Lavado-Valenzuela, Antonio Rueda Domínguez, Isabel Barragán, María Isabel Queipo-Ortuño
Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition. International journal of molecular sciences 23 (19) (2022)
Elisabeth Perez-Ruiz, Vanesa Gutiérrez, Marta Muñoz, Javier Oliver, Marta Sánchez, Laura Gálvez-Carvajal, Antonio Rueda-Domínguez, Isabel Barragán
Liquid Biopsy as a Tool for the Characterisation and Early Detection of the Field Cancerization Effect in Patients with Oral Cavity Carcinoma. Biomedicines 9 (10) (2021)
Jessica Gasca, M L Flores, Rocío Jiménez-Guerrero, María Eugenia Sáez, Isabel Barragán, M Ruíz-Borrego, M Tortolero, Francisco Romero, Carmen Saez, Miguel A Japón
EDIL3 promotes epithelial-mesenchymal transition and paclitaxel resistance through its interaction with integrin αVβ3 in cancer cells. Cell death discovery 6 (2020)

Isabel Barragán.css-eqlu8i{font-size:small;padding-left:4px;} (Isabel Barragan, I Barragán)

Publication Activity (10 Years)

Top Topics

Top Venues

Isabel Barragán (Isabel Barragan, I Barragán)